المؤلفون: Sha Yin, Yajing Chi, Yangyang Du, Jingfen Wang, Changping Shan, Weiwei Yi, Mao Shang, Xiaochu Man, Qiaorui Tan, Huihui Li

المصدر: Cancer Medicine, Vol 12, Iss 3, Pp 2333-2344 (2023)

مصطلحات موضوعية: efficacy, HER2‐positive breast cancer, pyrotinib, real‐world study, safety, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/462a0e8cef044d55a9f601770ef2bba2

المؤلفون: Yajing Chi, Mao Shang, Liang Xu, Heyi Gong, Rongjie Tao, Lihua Song, Baoxuan Zhang, Sha Yin, Binbin Cong, Huihui Li

المصدر: Frontiers in Oncology, Vol 12 (2022)

مصطلحات موضوعية: case report, leptomeningeal metastases, HER2-positive breast cancer, pyrotinib, metronomic vinorelbine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2022.811919/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/d50e93be61ad4b9c8aeb2d082f7e69d3

المؤلفون: Mao Shang, Yajing Chi, Jianbo Zhang, Jin Chang, Hui Yang, Sha Yin, Qiaorui Tan, Xiaochu Man, Huihui Li

المصدر: Frontiers in Oncology, Vol 11 (2022)

مصطلحات موضوعية: HER2-positive breast cancer, neoadjuvant trastuzumab plus chemotherapy, therapeutic effect, PD-L1, TILs, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fonc.2021.706606/full; https://doaj.org/toc/2234-943X

URL الوصول: https://doaj.org/article/54712d6ac5ad4e7f88624298129bee55

المؤلفون: Liu, Wenbin, Zhou, Tao, Huang, Dongli, Chen, Da, Mao, Shang, Xue, Chunhui, Wei, Dong

المصدر: In Annals of Nuclear Energy July 2024 202

المؤلفون: Yang, Hai-Bing^{Aff1, IDs1201102203478y_cor1}, Yuan, Wei, Li, Wei-Dong, Mao, Shang

المصدر: Biological Trace Element Research. 201(8):3941-3950

المؤلفون: Liu, Wenbin^{Aff2, Aff3, Aff4}, Zhou, Tao^{Aff2, Aff3, Aff4}, Wei, Dong^{Aff2, Aff3, Aff4}, Mao, Shang^{Aff2, Aff3, Aff4}, Xue, Chunhui^{Aff2, Aff3, Aff4}, Lu, Huaichang^{Aff2, Aff3, Aff4}, Yao, Yao^{Aff2, Aff3, Aff4}

المساهمون: Liu, Chengmin, editor^Aff1

المصدر: Proceedings of the 23rd Pacific Basin Nuclear Conference, Volume 3 : PBNC 2022, 1 - 4 November, Beijing & Chengdu, China. 285:890-903

المؤلفون: Wei, Dong^{Aff2, Aff3, Aff4}, Zhou, Tao^{Aff2, Aff3, Aff4}, Mao, Shang^{Aff2, Aff3, Aff4}, Liu, Wenbin^{Aff2, Aff3, Aff4}, Xue, Chunhui^{Aff2, Aff3, Aff4}, Lu, Huaichang^{Aff2, Aff3, Aff4}, Zhang, Yitong^{Aff2, Aff3, Aff4}

المساهمون: Liu, Chengmin, editor^Aff1

المصدر: Proceedings of the 23rd Pacific Basin Nuclear Conference, Volume 3 : PBNC 2022, 1 - 4 November, Beijing & Chengdu, China. 285:664-681

المؤلفون: Mao, Shang^{Aff2, Aff3, Aff4}, Zhou, Tao^{Aff2, Aff3, Aff4}, Xu, Peng^{Aff3, Aff5}, Zhou, Lanyu^Aff6

المساهمون: Liu, Chengmin, editor^Aff1

المصدر: Proceedings of the 23rd Pacific Basin Nuclear Conference, Volume 3 : PBNC 2022, 1 - 4 November, Beijing & Chengdu, China. 285:1191-1199

المؤلفون: Lu, Huaichang^{Aff2, Aff3, Aff4}, Zhou, Tao^{Aff2, Aff3, Aff4}, Liu, Wenbin^{Aff2, Aff3, Aff4}, Mao, Shang^{Aff2, Aff3, Aff4}, Wei, Dong^{Aff2, Aff3, Aff4}, Yao, Yao^{Aff2, Aff3, Aff4}, Gao, Tianyu^{Aff2, Aff3, Aff4}

المساهمون: Liu, Chengmin, editor^Aff1

المصدر: Proceedings of the 23rd Pacific Basin Nuclear Conference, Volume 1 : PBNC 2022, 1 - 4 November, Beijing & Chengdu, China. 283:742-752

المؤلفون: Mao, Shang, Zhou, Tao, Liu, Wenbin, Hu, Cheng, Xu, Peng

المصدر: In Energy 15 December 2023 285